ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Medicenna Therapeutics Corp

Medicenna Therapeutics Corp (MDNA)

1.85
0.01
(0.54%)
Closed December 26 4:12PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.85
Bid
1.82
Ask
1.88
Volume
29,147
1.78 Day's Range 1.98
0.385 52 Week Range 2.98
Market Cap
Previous Close
1.84
Open
1.80
Last Trade
100
@
1.87
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
81,978
Shares Outstanding
69,637,000
Dividend Yield
-
PE Ratio
-5.06
Earnings Per Share (EPS)
-0.37
Revenue
-
Net Profit
-25.47M

About Medicenna Therapeutics Corp

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Toronto, Ontario, Can
Founded
-
Medicenna Therapeutics Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Stock Exchange with ticker MDNA. The last closing price for Medicenna Therapeutics was $1.84. Over the last year, Medicenna Therapeutics shares have traded in a share price range of $ 0.385 to $ 2.98.

Medicenna Therapeutics currently has 69,637,000 shares outstanding. The market capitalization of Medicenna Therapeutics is $128.13 million. Medicenna Therapeutics has a price to earnings ratio (PE ratio) of -5.06.

MDNA Latest News

Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS)

Single-agent MDNA11 was more effective than a combination of immune checkpoint inhibitors (anti-mPD1 and anti-mCTLA4) in preventing metastasis and achieving long-term survival in an aggressive...

Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study

70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination with Merck’s (known as MSD outside of the US and...

Updated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference

TORONTO and HOUSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company...

Medicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO)

MDNA11 shows significant survival benefits in preclinical glioblastoma models, expanding CD8+ T and NK cells Bizaxofusp selectively targets human tumor cells and immune-suppressive cells...

Medicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression...

Medicenna Announces Upcoming Presentations at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO) and the 2024 San Antonio Breast Cancer Symposium (SABCS)

TORONTO and HOUSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company...

Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at the 39th Annual Meeting of SITC

Single-agent MDNA11 shows a 30% objective response rate (3 of 10) in the monotherapy dose expansion cohort among patients with advanced and/or metastatic solid tumors who had disease progression...

Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

   MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT (Bifunctional SuperKine for ImmunoTherapy), engineered to deliver an anti-PD1-IL-2 Superkine (anti-PD1-IL-2SK) to the tumor...

OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Medicenna...

Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in advanced or metastatic solid tumors Preclinical data on MDNA113, Medicenna's first-in-class...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.137.558139534881.721.981.65531551.74269414CS
40.095.113636363641.762.141.6612491.82263453CS
12-0.02-1.069518716581.872.621.27819781.98023637CS
26-0.08-4.145077720211.932.621.27740522.03452876CS
521.405315.7303370790.4452.980.3851026031.86191423CS
156-0.42-18.50220264322.272.980.215635351.4439818CS
260-0.79-29.92424242422.647.250.215734832.76585562CS

MDNA - Frequently Asked Questions (FAQ)

What is the current Medicenna Therapeutics share price?
The current share price of Medicenna Therapeutics is $ 1.85
How many Medicenna Therapeutics shares are in issue?
Medicenna Therapeutics has 69,637,000 shares in issue
What is the market cap of Medicenna Therapeutics?
The market capitalisation of Medicenna Therapeutics is CAD 128.13M
What is the 1 year trading range for Medicenna Therapeutics share price?
Medicenna Therapeutics has traded in the range of $ 0.385 to $ 2.98 during the past year
What is the PE ratio of Medicenna Therapeutics?
The price to earnings ratio of Medicenna Therapeutics is -5.06
What is the reporting currency for Medicenna Therapeutics?
Medicenna Therapeutics reports financial results in CAD
What is the latest annual profit for Medicenna Therapeutics?
The latest annual profit of Medicenna Therapeutics is CAD -25.47M
What is the registered address of Medicenna Therapeutics?
The registered address for Medicenna Therapeutics is 200 - 1920 YONGE STREET, TORONTO, ONTARIO, M4S 3E2
What is the Medicenna Therapeutics website address?
The website address for Medicenna Therapeutics is www.medicenna.com
Which industry sector does Medicenna Therapeutics operate in?
Medicenna Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GMTNGold Mountain Mining Corp
$ 0.035
(16.67%)
10k
XLYAuxly Cannabis Group Inc
$ 0.035
(16.67%)
378.93k
PPRPrairie Provident Resources Inc
$ 0.035
(16.67%)
390k
WRXWestern Resources Corp
$ 0.04
(14.29%)
3k
GFRGreenfire Resources Ltd
$ 10.09
(13.37%)
31.9k
RTGRTG Mining Inc
$ 0.025
(-37.50%)
100k
NCFNorthcliff Resources Ltd
$ 0.02
(-20.00%)
1.03M
KLSKelso Technologies Inc
$ 0.11
(-15.38%)
3.5k
AVLAvalon Advanced Materials Inc
$ 0.035
(-12.50%)
114k
YRBYorbeau Resources Inc
$ 0.035
(-12.50%)
110k
TTelus Corp
$ 19.45
(-1.52%)
4.87M
BBBlackBerry Limited
$ 5.65
(4.05%)
3.61M
ABXBarrick Gold Corporation
$ 22.55
(0.71%)
3.57M
BITFBitfarms Ltd
$ 2.45
(6.06%)
3.26M
FCUFission Uranium Corp
$ 0.72
(-2.70%)
2.54M

Discussion

View Full Feed
JSmith5 JSmith5 6 minutes ago
And let us not forget Neo's GSE Corollary ...
Governments can remain corrupt longer than you can remain invested and liquid

Yeah, for sure - I can think of at least one example of this.

Nats
FNMA
nowwhat2 nowwhat2 9 minutes ago
Wow !......You should see what those charts look like NOW !........UNBELIEVABLE



https://investorshub.advfn.com/uimage/uploads/2024/12/26/ymhxxBTC_121212_26_45d_130am_WOW_ON_DIE_PLAIN.jpg
XRPUSD
theorysuit theorysuit 14 minutes ago
from 2022 ASM

More of the same externalizing BS that the pump crew have been trained on by NWBO. Of course LP says the same BS externalizing blame game......SMFH when your CEO keeps crying instead of executing. Come on Pump crew let's keep blaming everyone but NWBO for their fail
ASM NWBO
cowtown jay cowtown jay 16 minutes ago
I answered your post. I'll try again.

What the charges signal to our partners is that we have a capable CEO to steer the ship.

I can't help but to reflect on the fact that Dale filed a motion to expedite this process, and then to consider that Sanofi had a Q4 target ac
Tahoe2468 Tahoe2468 21 minutes ago
KULR KULR KULR FOR TODAY 
KULR
Nextbigone Nextbigone 28 minutes ago
style="font-family: ".SFUI-Regular"; font-kerning: none"

MATH
Tahoe2468 Tahoe2468 30 minutes ago
Solid today breaks $4+ it's going to $7 in a hurry ! 
KULR
Bull_Dolphin Bull_Dolphin 31 minutes ago
Good morning Larry... Can't come soon enough!
TrendTrade2016 TrendTrade2016 36 minutes ago
ICCT HUGE GAPPER
ICCT
TrendTrade2016 TrendTrade2016 36 minutes ago
ICCT BREAKING 3.00 IN PRE
ICCT
Nextbigone Nextbigone 38 minutes ago
https://www.nasdaq.com/press-release/metalpha-technology-holding-limited-announces-us%245-million-share-repurchase-2023-02
MATH
Nextbigone Nextbigone 40 minutes ago
https://www.nasdaq.com/articles/asias-microstrategy:-metalpha-on-hedging-for-sustainable-investing
MATH
ten ten 41 minutes ago
who is Beckles if I may ask
EEGI
MagicalSphinx2 MagicalSphinx2 42 minutes ago
Purchasing an established AWS account offers numerous advantages over creating a new one. These include immediate access to a proven account with a positive track record, faster setup, and increased trust from clients or partners. By avoiding the hassle of building a new account from scratch, you sa
BIOCHEMUP BIOCHEMUP 47 minutes ago
Up in premarket, we see $3 soon.
ONDS
LWLG-Netherlands LWLG-Netherlands 47 minutes ago
This guy… so sad on Christmas eve… must be lonely! Hope you find friends soon. Take care
LWLG
Just the facts maam Just the facts maam 51 minutes ago
Hope you and your family have a happy holiday season as well.
Same goes for the rest of the board members.
ANIP
TrendTrade2016 TrendTrade2016 51 minutes ago
ONDS GAPPING HARD
ONDS
tw0122 tw0122 53 minutes ago
Subtract them ADD $5s + 100%
ADD
knrorrel knrorrel 58 minutes ago
watch on $DRCT and $NVNI with big dips now played down at the beginning and will the buyers come when they have all had enough sleep and in the afternoon buy the share $DRCT and $NVNI back into the green?
we'll see

both have really small FLOAT and can move quickly https://know
DRCT NVNI
knrorrel knrorrel 59 minutes ago
watch on $DRCT and $NVNI with big dips now played down at the beginning and will the buyers come when they have all had enough sleep and in the afternoon buy the share $DRCT and $NVNI back into the green?
we'll see

both have really small FLOAT and can move quickly https://know
DRCT NVNI
SkeBallLarry SkeBallLarry 1 hour ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 1 hour ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 1 hour ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 1 hour ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

Your Recent History

Delayed Upgrade Clock